The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Otto Dawn Parsell since 2019.
The trader's CIK number is 1748808.
At the time of the last reporting, Otto Dawn Parsell was the Sr VP, Clinical Development of Tricida, Inc.. (stock ticker symbol TCDA).
Also see all insider trading activities at Tricida, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TCDA | 0 | $0 | 21,250 | $716,189 | 21,250 | $59,777 |
| 2019 | TCDA | 0 | $0 | 62,418 | $2,098,741 | 61,346 | $82,618 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-08 | TCDA | Option Ex | 3,000 | 3.31 | 9,930 |
| 2020-05-08 | TCDA | Sale | 3,000 | 31.98 | 95,940 |
| 2020-05-05 | TCDA | Option Ex | 1,250 | 2.04 | 2,543 |
| 2020-05-05 | TCDA | Sale | 1,250 | 30.18 | 37,725 |
| 2020-04-28 | TCDA | Sale | 1,250 | 29.98 | 37,475 |
| 2020-04-29 | TCDA | Sale | 3,000 | 31.98 | 95,940 |
| 2020-04-28 | TCDA | Option Ex | 1,250 | 1.68 | 2,100 |
| 2020-04-29 | TCDA | Option Ex | 3,000 | 3.31 | 9,930 |
| 2020-03-02 | TCDA | Sale | 4,250 | 31.93 | 135,702 |
| 2020-03-02 | TCDA | Option Ex | 4,250 | 3.31 | 14,067 |
| 2020-02-03 | TCDA | Option Ex | 4,250 | 3.31 | 14,067 |
| 2020-02-03 | TCDA | Sale | 4,250 | 36.72 | 156,072 |
| 2020-01-02 | TCDA | Sale | 4,250 | 37.02 | 157,335 |
| 2020-01-02 | TCDA | Option Ex | 4,250 | 1.68 | 7,140 |
| 2019-11-26 | TCDA | Sale | 5,746 | 39.60 | 227,541 |
| 2019-11-26 | TCDA | Option Ex | 5,746 | 1.62 | 9,325 |
| 2019-10-28 | TCDA | Sale | 5,300 | 37.48 | 198,628 |
| 2019-10-28 | TCDA | Option Ex | 5,300 | 2.04 | 10,785 |
| 2019-09-25 | TCDA | Option Ex | 5,300 | 1.68 | 8,904 |
| 2019-09-25 | TCDA | Sale | 5,300 | 32.65 | 173,029 |
| 2019-08-28 | TCDA | Option Ex | 5,000 | 1.68 | 8,400 |
| 2019-08-28 | TCDA | Sale | 5,000 | 33.69 | 168,425 |
| 2019-07-29 | TCDA | Option Ex | 5,000 | 1.68 | 8,400 |
| 2019-07-29 | TCDA | Sale | 5,000 | 31.19 | 155,950 |
| 2019-07-03 | TCDA | Option Ex | 15,000 | 1.39 | 20,805 |
| 2019-07-03 | TCDA | Sale | 15,407 | 37.04 | 570,675 |
| 2019-03-28 | TCDA | Sale | 15,500 | 30.74 | 476,470 |
| 2019-03-28 | TCDA | Option Ex | 15,500 | .80 | 12,400 |
| 2019-03-15 | TCDA | Option Ex | 771 | .80 | 616 |
| 2019-03-15 | TCDA | Sale | 771 | 25.02 | 19,290 |
| 2019-03-18 | TCDA | Option Ex | 1,729 | .80 | 1,383 |
| 2019-03-18 | TCDA | Sale | 1,729 | 25.02 | 43,259 |
| 2019-03-13 | TCDA | Sale | 2,000 | 25.00 | 50,000 |
| 2019-03-13 | TCDA | Option Ex | 2,000 | .80 | 1,600 |
| 2019-01-07 | TCDA | Sale | 665 | 23.27 | 15,474 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Otto Dawn Parsell (Sr VP, Clinical Development of Tricida, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.